Tazarotene
Overview
Tazarotene is a third-generation prescription topical retinoid used for the treatment of psoriasis, acne, and sun-damaged skin. It works by modulating skin cell growth and reducing inflammation.
API suppliers (6)
Suppliers of Tazarotene evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
5 of 6 hold a GMP certificate on record in the EU or UK registers
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- PCASFrance1 active DMF GMP on record
- OLON SPAItaly1 active DMF GMP on record
- Piramal Healthcare (Canada) LimitedCanada
- BASF SEGermany GMP on record
- WATSON PHARMA PRIVATE LTD GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (18 approved US products), the latest listed US patent on Tazarotene expires 11 May 2038. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Tazarotene? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.